A Perfect Match in Healthcare Market Research

Welcome back to Intellicast! On this special episode of Intellicast, Brian and Gabby are joined by Konovo’s CEO, Tal Rosenberg, and the President and Founder of Rare Patient Voice, Wes Michael. They join the podcast to provide details around Konovo’s recent acquisition of Rare Patient Voice, and what it means for healthcare research.

Kicking off the interview, Tal and Wes provide background on their respective organizations and how they evolved over time. Rare Patient Voice was built on the idea of giving patients, particularly those with rare conditions, a platform to share their experiences, while Konovo has focused on helping researchers more effectively find and engage specialized audiences across healthcare.

The conversation then shifts to the acquisition itself and the rationale behind it. Tal explains that the goal is not simply to combine companies, but to build a more integrated approach to research, one that brings together both the patient and healthcare provider perspectives in a more seamless way. The ability to access both audiences within a single ecosystem reflects a broader trend in healthcare research, where understanding multiple viewpoints is becoming increasingly important.

Wes adds that alignment in values played a significant role in the decision. With a shared focus on patient-first research, quality, and long-term relationships, both organizations saw an opportunity to expand their capabilities without compromising what made each successful on its own.

The two also explore how the combined organization plans to evolve. While Rare Patient Voice will maintain its existing approach in the near term, the integration of Konovo’s technology and infrastructure is expected to enhance speed, scale, and operational efficiency.

A key theme throughout the interview is the importance of maintaining trust. Wes emphasizes that preserving the experience and expectations of patient participants is critical, while Tal highlights the need to scale responsibly as the organization grows. Both note that while new tools and technologies will play a role, they must be implemented in a way that supports, not disrupts, the core mission.

In the final segment, the group reflects on what comes next, including opportunities for expansion, deeper integration, and continued investment in both technology and audience development.

You can learn more about Konovo by visiting their website: https://konovo.com/

You can learn more about Rare Patient Voice by visiting their website: https://rarepatientvoice.com/

You can also connect with Tal and Wes on LinkedIn here:

Tal: https://www.linkedin.com/in/talrosenberg/

Wes: https://www.linkedin.com/in/wesmichael/

Thanks for tuning in!

We’ve launched our new whitepaper, The Fraud Detection Reality Check. Get your copy and find out why relying on a single fraud detection tool is a mistake. Download here: https://content.emi-rs.com/fraud-detection-report  

Did you miss one of our webinars or want to get some of our whitepapers and reports? You can find it all on our Resources page on our website here: https://emi-rs.com/resources/